Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $89.0800 (3.62%) ($86.9000 - $90.4600) on Tue. Feb. 16, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.82% (three month average) | RSI | 28 | Latest Price | $89.0800(3.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.1% a day on average for past five trading days. | Weekly Trend | LGND declines -6.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(52%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.41% in a week (0% probabilities). VIXM(-16%) TLT(-16%) UUP(-7%) GDXJ(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.41% (StdDev 2.82%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
1 - 5 Day Possible Target | $78.32(-12.08%) | Resistance Level | $95.59 | 5 Day Moving Average | $87.74(1.53%) | 10 Day Moving Average | $91.57(-2.72%) | 20 Day Moving Average | $95.59(-6.81%) | To recent high | -20.4% | To recent low | 3.8% | Market Cap | $1.432b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |